Taiwan International Ports Corporation (TIPC) is pleased to announce its Kaohsiung Port Cruise Terminal building has won two ...

Today at CES 2026, AMD Chair and CEO Dr. Lisa Su detailed in the show's opening keynote how the company's extensive portfolio of AI products and deep cross-industry collaborations are turning the ...

Today at CES 2026, AMD unveiled its latest generation of mobile and desktop processors that expand its client computing portfolio, bringing expanded AI capabilities, premium gaming performance, and ...

Eisai serves as the lead of LEQEMBI development and regulatory submissions globally with Eisai and Biogen co-commercializing and co-promoting the product and Eisai having final decision-making ...

After nearly three years of building its own version of cutting-edge large language models, Amazon has come up with models ...

Distributed on behalf of K2 Gold Corporation Gold last traded at $4,448.41 and could easily test $5,000. All of which is a ...

Lucara Diamond Corp. ("Lucara" or the "Company") is pleased to announce the results of an updated technical report (the "Report") for the updated Feasibility Study ("FS" or "Study"), prepared in ...

VANCOUVER, BC, Jan. 5, 2026 /CNW/ - Lucara Diamond Corp. (TSX: LUC) (BSE: LUC) (Nasdaq First North: LUC) ("Lucara" or the "Company") is pleased to ...

The trial aims to establish clinical proof-of-concept in psoriasis and proof-of-mechanism for other CCR6- and Th17-associated autoimmune indications Allschwil, Switzerland - January 6, 2026Idorsia ...

VANCOUVER, BC, Jan. 5, 2026 /PRNewswire/ -- (TSX: LUC) (BSE: LUC) (Nasdaq First North: LUC) Lucara Diamond Corp. ("Lucara" or the "Company") is pleased to announce the results of an updated ...

Together, ZF and Qualcomm Technologies aim to deliver a future-proof ADAS compute platform that supports the rapid advancement of automated driving, enhances vehicle safety, and aligns with the ...

GSK has secured approval in Japan for Exdensur (depemokimab), the country’s first ultra-long-acting biologic for severe asthma and chronic rhinosinusitis with nasal polyps. Approved by Japan’s ...